Ignite Creation Date:
2024-05-05 @ 11:00 PM
Last Modification Date:
2024-10-26 @ 10:27 AM
Study NCT ID:
NCT01232062
Status:
COMPLETED
Last Update Posted:
2015-07-23
First Post:
2010-10-29
Brief Title:
Study of High-dose Chemotherapy HDC Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
Sponsor:
Organization:
Peking University Cancer Hospital Institute
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
NONE_RETAINED
Bio Spec Description:
about 4ml peripheral vein bloodparaffin section on metastatic tissue
Enrollment Count:
46
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 12668 |
Who Masked List: